Pfizer, BioNTech team up with Brazil’s Eurofarma to make COVID-19 vaccine for Latin America

Seeking Alpha2021-08-26

Pfizer (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have signeda letter of intent with Brazil-based Eurofarma Laboratórios SA, to manufacture its mRNACOVID-19 vaccine, COMIRNATY for distribution within ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

TradeLegend
2021-08-26
TradeLegend
🤑
- TradeLegend:
  👍
PEIYONG
2021-08-26
PEIYONG
Pls like
- ngph:
  Ok
- RoarLionRoar:
  Good
- SKLow:
  [微笑]
- SKLow:
  like and comment back pls.tq
- GinOng:
  Good thing
Btfan
2021-08-26
Btfan
Ok
ycwoo
2021-08-26
ycwoo
Like
- MunYee531:
  Ok
JaxW
2021-08-26
JaxW
Please like and comment 🙏 Thanks
- Btfan:
  Ok

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1131132146?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-08-26 19:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131132146","market":"us","top_or_hot":-1,"title":"Pfizer, BioNTech team up with Brazil’s Eurofarma to make COVID-19 vaccine for Latin America","media":"Seeking Alpha","content":"<div>\n<p>Pfizer (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have signeda letter of intent with Brazil-based Eurofarma Laboratórios SA, to manufacture its mRNACOVID-19 vaccine, COMIRNATY for distribution within ...</p>\n\n<a href=\"https://seekingalpha.com/news/3734357-pfizer-biontech-team-up-with-brazils-eurofarma-to-make-covid-19-vaccine-for-latin-america\">网页链接</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, BioNTech team up with Brazil’s Eurofarma to make COVID-19 vaccine for Latin America</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, BioNTech team up with Brazil’s Eurofarma to make COVID-19 vaccine for Latin America\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 19:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3734357-pfizer-biontech-team-up-with-brazils-eurofarma-to-make-covid-19-vaccine-for-latin-america><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have signeda letter of intent with Brazil-based Eurofarma Laboratórios SA, to manufacture its mRNACOVID-19 vaccine, COMIRNATY for distribution within ...</p>\n\n<a href=\"https://seekingalpha.com/news/3734357-pfizer-biontech-team-up-with-brazils-eurofarma-to-make-covid-19-vaccine-for-latin-america\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"https://seekingalpha.com/news/3734357-pfizer-biontech-team-up-with-brazils-eurofarma-to-make-covid-19-vaccine-for-latin-america","article_id":"1131132146","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131132146","pubTimestamp":1629977943,"columns":[],"sourceInfo":null,"weMediaInfo":null,"summary":"Pfizer (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have signeda letter of intent with Brazil-based Euro","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"translate_title":"辉瑞生物技术公司与巴西欧洲农场公司合作为拉丁美洲生产新冠肺炎疫苗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNTX":0.9,"PFE":0.9},"content_text":"Pfizer (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have signeda letter of intent with Brazil-based Eurofarma Laboratórios SA, to manufacture its mRNACOVID-19 vaccine, COMIRNATY for distribution within Latin America.\nEurofarma will obtain drug product drug product from the U.S., and will perform manufacturing activities, with distribution expected to start in 2022.\nPfizer-BioNTech's COVID-19 vaccine supply chain and manufacturing network will now span four continents and include more than 20 manufacturing facilities.\nAt full operational capacity, the annual production is expected to exceed 100M finished doses annually. All doses will exclusively be distributed within Latin America.\nTo date, Pfizer and BioNTech have shipped more than 1.3B COVID-19 vaccine doses to more than 120 countries and territories.\nRecently, Pfizer/BioNTech started rolling submission for FDA approval of booster COVID-19 shot.","kind":"news","is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":810291337,"gmtCreate":1629978170129,"gmtModify":1631891867708,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/810291337","repostId":1131132146,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5655819,"gmtCreate":1629978182172,"gmtModify":1631891867708,"authorId":3565930395680990,"author":{"id":3565930395680990,"idStr":"3565930395680990","authorId":3565930395680990,"name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":810291337,"type":1,"supId":0,"prevId":0,"content":"👍","text":"👍","html":"👍"}],"langContent":"EN"},{"id":810293549,"gmtCreate":1629978146481,"gmtModify":1631888374558,"author":{"id":"3587085062023538","authorId":"3587085062023538","name":"PEIYONG","avatar":"https://static.tigerbbs.com/d91e7a49d44f9756fece9556769c80bd","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3587085062023538","authorIdStr":"3587085062023538"},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/810293549","repostId":1131132146,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5656481,"gmtCreate":1629983079617,"gmtModify":1631888374617,"authorId":3581841475262844,"author":{"id":3581841475262844,"idStr":"3581841475262844","authorId":3581841475262844,"name":"ngph","avatar":"https://static.tigerbbs.com/184d156a6098c9891cc55260418562f6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":810293549,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":5655916,"gmtCreate":1629979056081,"gmtModify":1631888374603,"authorId":4089549058639000,"author":{"id":4089549058639000,"idStr":"4089549058639000","authorId":4089549058639000,"name":"RoarLionRoar","avatar":"https://static.tigerbbs.com/acf1b92090d515ae9f135d5b65ef3fc4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":810293549,"type":1,"supId":0,"prevId":0,"content":"Good","text":"Good","html":"Good"},{"id":5655869,"gmtCreate":1629978535963,"gmtModify":1631888374592,"authorId":3582927789816025,"author":{"id":3582927789816025,"idStr":"3582927789816025","authorId":3582927789816025,"name":"SKLow","avatar":"https://static.tigerbbs.com/b3aeaabd2ee1ec9afcdda5a4aab1994c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":810293549,"type":1,"supId":5655868,"prevId":0,"content":"[微笑]","text":"[微笑]","html":"[微笑]"},{"id":5655868,"gmtCreate":1629978524001,"gmtModify":1631888374576,"authorId":3582927789816025,"author":{"id":3582927789816025,"idStr":"3582927789816025","authorId":3582927789816025,"name":"SKLow","avatar":"https://static.tigerbbs.com/b3aeaabd2ee1ec9afcdda5a4aab1994c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":810293549,"type":1,"supId":0,"prevId":0,"content":"like and comment back pls.tq","text":"like and comment back pls.tq","html":"like and comment back pls.tq"},{"id":5655839,"gmtCreate":1629978337971,"gmtModify":1631888374565,"authorId":3585489224255758,"author":{"id":3585489224255758,"idStr":"3585489224255758","authorId":3585489224255758,"name":"GinOng","avatar":"https://static.tigerbbs.com/dbc4f4af938fe9cbc71173da2486f50b","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":810293549,"type":1,"supId":0,"prevId":0,"content":"Good thing","text":"Good thing","html":"Good thing"}],"langContent":"EN"},{"id":810299584,"gmtCreate":1629978067248,"gmtModify":1631893200297,"author":{"id":"3584159414301653","authorId":"3584159414301653","name":"Btfan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3584159414301653","authorIdStr":"3584159414301653"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/810299584","repostId":1131132146,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":810290123,"gmtCreate":1629978011462,"gmtModify":1631891956146,"author":{"id":"3565146699964497","authorId":"3565146699964497","name":"ycwoo","avatar":"https://static.tigerbbs.com/637be28a03f575af22b76a60dad1181b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3565146699964497","authorIdStr":"3565146699964497"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/810290123","repostId":1131132146,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5655958,"gmtCreate":1629979477046,"gmtModify":1635138706601,"authorId":3585631130131196,"author":{"id":3585631130131196,"idStr":"3585631130131196","authorId":3585631130131196,"name":"MunYee531","avatar":"https://static.tigerbbs.com/a570dfe3bfa096d02d0a12bb44ec4b17","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":810290123,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":810290972,"gmtCreate":1629977996596,"gmtModify":1631887973012,"author":{"id":"3582635042920976","authorId":"3582635042920976","name":"JaxW","avatar":"https://static.tigerbbs.com/e387971df14a5a7a9d52e133338baf77","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3582635042920976","authorIdStr":"3582635042920976"},"htmlText":"Please like and comment 🙏 Thanks&nbsp;","listText":"Please like and comment 🙏 Thanks&nbsp;","text":"Please like and comment 🙏 Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/810290972","repostId":1131132146,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5655807,"gmtCreate":1629978092212,"gmtModify":1631887973014,"authorId":3584159414301653,"author":{"id":3584159414301653,"idStr":"3584159414301653","authorId":3584159414301653,"name":"Btfan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":810290972,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":51,"commentSize":5,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1131132146"}